EDIT Q2 2022 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+1578.6% YoY

Gross Profit

-$37M-586.2% margin

Operating Income

-$54M-852.5% margin

Net Income

-$53M-840.2% margin

EPS (Diluted)

$-0.77

QoQ Revenue Growth

-6.0%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$581M

Total Liabilities

$115M

Stockholders' Equity

$465M

Cash & Equivalents

$169M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$379,000	+1578.6%
Gross Profit	-$37M	-$33M	-11.8%
Operating Income	-$54M	-$55M	+2.1%
Net Income	-$53M	-$55M	+3.3%